Safety in Numbers: Keeping AI Open
The a16z Show11 Joulu 2023

Safety in Numbers: Keeping AI Open

Arthur Mensch is the co-founder of Mistral and the co-author of Deepmind’s pivotal 2022 "Chinchilla" paper.

In September 2023, Mistral released Mistral-7B, an advanced open-source language model that has rapidly become the top choice for developers. Just this week, they introduced a new mixture of experts model – Mixtral — that’s already generating significant buzz among AI developers.

As the battleground around large language models heats up, join us for a conversation with Arthur as he sits down with a16z General Partner Anjney Midha. Together, they delve into the misconceptions and opportunities around open source; the current performance reality of open and closed models; and the compute, data, and algorithmic innovations required to efficiently scale LLMs.

Resources:

Find Arthur on Twitter: https://twitter.com/arthurmensch

Find Anjney on Twitter: https://twitter.com/anjneymidha

Learn more about Mistral: https://mistral.ai

Learn why we invested in Mistral: https://a16z.com/announcement/investing-in-mistral/

Stay Updated:

Find a16z on Twitter: https://twitter.com/a16z

Find a16z on LinkedIn: https://www.linkedin.com/company/a16z

Subscribe on your favorite podcast app: https://a16z.simplecast.com/

Follow our host: https://twitter.com/stephsmithio

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.

Stay Updated:

Find a16z on YouTube: YouTube

Find a16z on X

Find a16z on LinkedIn

Listen to the a16z Show on Spotify

Listen to the a16z Show on Apple Podcasts

Follow our host: https://twitter.com/eriktorenberg

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Jaksot(1000)

The Truth about 1000 True Fans + Pricing Our Attention

The Truth about 1000 True Fans + Pricing Our Attention

The idea of "1000 true fans" -- first proposed by Kevin Kelly in 2008 and later updated for Tools of Titans -- argued that to be a successful creator, you don’t need millions of customers or clients, ...

27 Tammi 202015min

Writers Writing, Readers Reading, Creators Creating

Writers Writing, Readers Reading, Creators Creating

We've been financing good writing with bad advertising -- and "attention monsters" (to quote Craig Mod) for way too long. So what happens when the technology for creators finally falls into place? We'...

27 Tammi 202040min

What's Next for the Internet?

What's Next for the Internet?

How can we evolve the web for a better future? Has the web become a mature platform — or are we still in the early days of knowing what it can do and what role it might have in our lives? Just as “soc...

19 Tammi 202041min

Controlling AI

Controlling AI

AI can do a lot of specific tasks as well as, or even better than, humans can — for example, it can more accurately classify images, more efficiently process mail, and more logically manipulate a Go b...

16 Tammi 202026min

Food, Drugs, and Tech—100 Years of Public Health

Food, Drugs, and Tech—100 Years of Public Health

The federal agency known as the FDA, or the Food and Drug Administration, was born over 100 years ago—at the turn of the industrial revolution, in a time of enormous upheaval and change, and rapidly e...

14 Tammi 202044min

On Pharma Trends and Big Company Innovation

On Pharma Trends and Big Company Innovation

How does the world’s largest producer of medicines in terms of volume balance the science and the business of innovation? How does an enterprise at such vast scale make decisions about what to build v...

11 Tammi 202059min

Personal Genomics: Where Are We, Really?

Personal Genomics: Where Are We, Really?

This is a turn of the decade (and January-themed) look backward/ look forward into personal genomics, given recent and past retrospective and prospective pieces in the media on the promise, and perils...

6 Tammi 202019min

Why We Should Be Optimistic About the Future

Why We Should Be Optimistic About the Future

Many skeptics thought the internet would never reach mass adoption, but today it’s shaping global culture, is integral to our lives -- and it's just the beginning. In this conversation from our 2019 i...

2 Tammi 202044min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
rss-rahapodi
psykopodiaa-podcast
rss-rahamania
herrasmieshakkerit
ostan-asuntoja-podcast
rss-seuraava-potilas
rss-20-30-40-podcast
rahapuhetta
rss-inderes-femme
rss-paasipodi
rss-myynnilla-on-asiaa-kert-kenner
taloudellinen-mielenrauha
rss-sami-miettinen-neuvottelija
yrittaja
raksapodi
rss-lahtijat
rss-startup-ministerio
rss-sisalto-kuntoon